Carter DeLuca’s legal and technical expertise includes a wide range of life science industries and is the perfect prescription for our clients to execute effective IP strategies to protect and commercially exploit their innovations.
Whether you are a start-up company or a multi-national conglomerate developing a small molecule, biologic, nutraceutical, cosmeceutical, or agriculture product, Carter DeLuca will proactively take the time to understand your science and business to provide direct, cost-effective strategic advice regarding positioning your IP portfolio, navigating the competitive IP landscape, and dealing with potential partners (whether for licensing or strategic alliances).
The firm’s pharmaceutical and biotech expertise covers a wide range of therapeutic areas. By combining deep knowledge of the pharma/biotech arts with industry knowledge and legal expertise, our attorneys work closely with your technical and business teams to define and implement a coordinated IP strategy during all stages of the drug product development process to advances your goals, and helps you see the bigger picture, identifying potential issues and opportunities.
A sampling of the diverse life science technologies in which we have expertise includes:
- Antibody Technologies
- Combinational Libraries
- Microarray Diagnostics
- Molecular Modeling
- Phage Display
- Recombinant Technologies
- Single Nucleotide Polymorphisms (SNPs)
- Active Pharmaceutical Ingredients
- Pharmaceutical Solid Polymorphism
- Dosage Formulations
- Dosage Delivery Systems
- Vitamin Formulations
- Nutritional Supplements
- Acne Treatments
- Cosmetic formulation
Chemical and Biological Technologies in Agriculture
- Plant Protection Products
- Genetically Modified Organisms